Background: In patients with a first unprovoked venous thrombo-embolism (VTE), an elevated D-dimer level after anticoagulation is stopped is a risk factor for recurrent VTE. However, questions remain about the utility of measuring D-dimer in clinical practice. Purpose: To determine whether the timing of testing, patient age, and the cut point used to define a positive or negative result affect the ability of D-dimer testing to distinguish risk for recurrent disease
The Prolong study shows that continuing vitamin K antagonists (VKA) in patients with abnormal D: -di...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thrombo...
Background: In patients with a first unprovoked venous thromboembolism (VTE), an elevated D-dimer le...
Objective: Venous thromboembolism (VTE) recurrence is a major concern after a first symptomatic epis...
BACKGROUND Whether post-anticoagulation D-dimer levels are useful in predicting recurrence in eld...
Recurrent thrombosis is a relatively frequent complication of venous thromboembolism (VTE) and repre...
The PROLONG randomized trial showed that a normal D-dimer (D-d) 1 month after anticoagulation suspen...
The optimal duration of anticoagulation after recurrent venous thromboembolism(VTE) is poorly establ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
Objective: We compared the performance of aggregate data (AD)–based and individual patient data (IPD...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
International audienceBACKGROUND: D-dimer levels remain elevated in many patients after completion o...
Background. Strategies combining pretest clinical assessment and D-dimers measurement efficiently an...
The Prolong study shows that continuing vitamin K antagonists (VKA) in patients with abnormal D: -di...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thrombo...
Background: In patients with a first unprovoked venous thromboembolism (VTE), an elevated D-dimer le...
Objective: Venous thromboembolism (VTE) recurrence is a major concern after a first symptomatic epis...
BACKGROUND Whether post-anticoagulation D-dimer levels are useful in predicting recurrence in eld...
Recurrent thrombosis is a relatively frequent complication of venous thromboembolism (VTE) and repre...
The PROLONG randomized trial showed that a normal D-dimer (D-d) 1 month after anticoagulation suspen...
The optimal duration of anticoagulation after recurrent venous thromboembolism(VTE) is poorly establ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
Objective: We compared the performance of aggregate data (AD)–based and individual patient data (IPD...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
International audienceBACKGROUND: D-dimer levels remain elevated in many patients after completion o...
Background. Strategies combining pretest clinical assessment and D-dimers measurement efficiently an...
The Prolong study shows that continuing vitamin K antagonists (VKA) in patients with abnormal D: -di...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thrombo...